How We Partner With PCPs, Mental Health Professionals and PHP/IOP Programs
NeuroGlow adds IV ketamine and Spravato (esketamine) to the care your patients already receive from you. We do not replace the primary care physician, the therapist, the prescriber or the program; we work alongside each of them, with one evaluation, one point of contact and progress you can see.
Refer a patient Set up a partnership 469-218-4410 · Fax 972-474-3544
What every partner gets
One evaluation, two options
Every NeuroGlow clinic offers both Spravato and IV ketamine. A psychiatric evaluation by our clinical team determines which fits the patient’s diagnosis and coverage, so you refer once.
Coverage handled
Spravato is in-network with most commercial plans and TRICARE including TriWest, and we accept Medicare. We verify coverage (about 10 minutes), confirm costs in writing, and handle prior authorization when a plan requires it (3 to 5 business days for most plans). Financial assistance programs are available, and we help patients enroll to reduce out-of-pocket costs. IV ketamine is self-pay with published pricing.
Progress you can see
PHQ-9 at intake and through care. With the patient’s authorization you receive the evaluation summary, the treatment plan and progress notes, and the patient’s ongoing care stays with you.
How we partner with primary care physicians
Most of the patients we see have been managed well in primary care and have simply run out of options: two or more antidepressant trials without adequate relief, side effects that limit dosing, or depression that keeps undermining a chronic condition you are treating. NeuroGlow gives you a specialist pathway for those patients without sending them out of your practice.
- Who to refer. Adults with depression that has not responded to at least two antidepressants, with PTSD or anxiety that is not responding to standard care, or with depression alongside chronic pain. If you are unsure, refer anyway; the evaluation decides.
- What to send. Current medication list, antidepressant history (what was tried, at what dose, for how long), relevant diagnoses, and any recent PHQ-9 or GAD-7. The referral form collects the essentials; a fax of the last progress note works too.
- What stays with you. Primary care, chronic disease management and the patient’s oral antidepressant, which continues during Spravato treatment. We do not assume medication management.
- What you get back. The evaluation summary and recommendation, then progress updates with PHQ-9 scores, and a clear handoff note when the induction series is complete.
How we partner with mental health professionals
Therapists, psychologists, psychiatrists and psychiatric nurse practitioners are the partners we work with most. Ketamine and Spravato are not a substitute for therapy; in our experience the weeks after treatment are when therapy has the most to work with, and we build the schedule around yours.
- Therapy continues. Your patient keeps seeing you throughout treatment. We encourage every patient to have a therapist; if they arrive without one, we introduce them to clinicians we trust.
- Integration timed with your sessions. The IV ketamine induction series includes one integration session with our team; we coordinate the timing so it complements rather than duplicates your work, and we share what came up in treatment when the patient wants us to.
- For prescribers. You keep medication management. Spravato is administered in our clinic under the REMS program alongside the patient’s oral antidepressant, which stays on your pad. We send a medication reconciliation before the first dose and flag anything that needs your decision.
- Integrative therapy session. The $3,500 induction series includes six infusions, all intake appointments and one integrative therapy session with our clinicians. For patients who want more therapy during the series, we can coordinate infusion days with your sessions.
- Both directions. Patients who inquire with us and need ongoing therapy or medication management are referred to partners we know.
How we partner with PHP and IOP programs
Partial hospitalization and intensive outpatient programs see the patients who need the most help and have the least time. We work with programs in two directions: patients who need an interventional option during the program, and patients stepping down with residual symptoms who need something more than a return to weekly care.
- During the program. We schedule around program hours. McKinney has Tuesday and Thursday evening hours and Saturday availability; Flower Mound has Wednesday evening and Saturday morning hours; Fort Worth runs Monday, Wednesday and Friday. Treatment visits are about 90 minutes in the clinic for IV ketamine and about 2 hours and 15 minutes for Spravato including observation.
- Before discharge. Send the referral while the patient is still in the program and we start benefits verification and prior authorization right away, so the first evaluation can be scheduled around the discharge date rather than after it.
- Suicidal ideation. Patients with depression and suicidal ideation are evaluated on the Spravato pathway by our clinical team. We coordinate safety planning with your clinical team and do not treat as a crisis service; patients in acute crisis need emergency care first (988 or 911).
- Program-level coordination. One NeuroGlow contact for your program, a shared release of information process, discharge summaries sent to your clinical lead, and a standing slot for case conferences if your team wants one.
- Transportation. Patients cannot drive until the next day, after a restful night’s sleep. We will tell you this at referral so your discharge planning can account for it.
What a partnership looks like
- Introductory call or clinic tour. Meet the clinical team, see the treatment rooms, and agree on how referrals and communication will flow.
- Referral channel. Online referral form, fax, or a direct line to our intake team for your office.
- Shared facts. We send a one-page summary of our services, pricing and coverage so your staff can answer first questions. Everything on it is on this site.
- Feedback loop. Evaluation summary, treatment plan and PHQ-9 updates for every shared patient, and a quarterly check-in on how the partnership is working.
Hear from partner clinicians
[Partner testimonials to be added: name, credential and practice, with written permission.]
Start the conversation
Email info@neuroglow.com with your practice or program name and the best time to talk, or call 469-218-4410. To refer a patient today, use the referral form or fax 972-474-3544. Patient-facing guides for preparation, medications, insurance and what to expect are collected on our provider resources page.
If a patient is in crisis or thinking about suicide, call or text 988 (Suicide and Crisis Lifeline, 24/7) or call 911. Veterans: dial 988, then press 1.